Answers are grounded in this paper and cite their sources.
In vitro experiment demonstrates that BBP mediates beta-amyloid toxicity in human neurons, suggesting a novel signaling pathway in Alzheimer's disease pathophysiology.
Degeneration of neurons in Alzheimer's disease is mediated by beta-amyloid peptide by diverse mechanisms, which include a putative apoptotic component stimulated by unidentified signaling events. This report describes a novel beta-amyloid peptide-binding protein (denoted BBP) containing a G protein-coupling module. BBP is one member of a family of three proteins containing this conserved structure. The BBP subtype bound human beta-amyloid peptide in vitro with high affinity and specificity. Expression of BBP in cell culture induced caspase-dependent vulnerability to beta-amyloid peptide toxicity. Expression of a signaling-deficient dominant negative BBP mutant suppressed sensitivity of human Ntera-2 neurons to beta-amyloid peptide mediated toxicity. These findings suggest that BBP is a target of neurotoxic beta-amyloid peptide and provide new insight into the molecular pathophysiology of Alzheimer's disease.
No takes yet. Share an insight, caveat, or question.
Kajkowski et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: